companydata.dkcompanydata.dk

Pharma Equity Group A/S: Financial statements 2015

CVR: 26791413

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -3,742,000 compared with DKK -5,930,000 the year before. Equity in the 2015 report amounted to DKK 99,533,000. The solvency ratio was 78.8%.

Profit/Loss
DKK -3,742,000
Equity
DKK 99,533,000
Total Assets
DKK 126,255,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015---3.7 mio.99.5 mio.-
201400-5.9 mio.98 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Pharma Equity Group A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

Peer Henning Borg joins Pharma Equity Group A/S as adm. dir.Dec 30, 2015

As of December 30, 2015, Peer Henning Borg is registered as adm. dir. of Pharma Equity Group A/S.

Staffan Mattson steps down as adm. dir. of Pharma Equity Group A/SDec 30, 2015

As of December 30, 2015, Staffan Mattson has stepped down as adm. dir. of Pharma Equity Group A/S.

Pharma Equity Group A/S: The 2014 annual report is outApr 15, 2015

Pharma Equity Group A/S has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK -5,930,000.

Leif Reinholdt Erlandsen joins the board of Pharma Equity Group A/SMar 27, 2015

As of March 27, 2015, Leif Reinholdt Erlandsen has joined the board of directors of Pharma Equity Group A/S.

Christian Gersdorff Stenbjerre joins the board of Pharma Equity Group A/SMar 27, 2015

As of March 27, 2015, Christian Gersdorff Stenbjerre has joined the board of directors of Pharma Equity Group A/S.

Claus Abildstrøm joins the board of Pharma Equity Group A/SMar 27, 2015

As of March 27, 2015, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.

Claus Abildstrøm leaves the board of Pharma Equity Group A/SMar 26, 2015

As of March 26, 2015, Claus Abildstrøm has left the board of directors of Pharma Equity Group A/S.

Pharma Equity Group A/S appoints new auditorFeb 2, 2015

As of February 2, 2015, KPMG P/S has been appointed auditor of Pharma Equity Group A/S.

Auditor steps down at Pharma Equity Group A/SFeb 2, 2015

As of February 2, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Pharma Equity Group A/S.

About Pharma Equity Group A/S

Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.

Source: annual report 2025, Danish Business Authority